Orfo Drive Capsules (Orforglipron / SLU-PP-332)
Third-party testedOrforglipron (a non-peptide GLP-1 receptor agonist) and SLU-PP-332 per capsule, for metabolic research.
$91
$130
/ 60 capsules ·
USD
The Peplogy Purity Promise
Every lot verified ≥99% by HPLC and mass spectrometry, endotoxin screened, and shipped with its lot-matched COA.
- Certificate of Analysis for every lot
- ≥99% purity, HPLC & mass-spec verified
- Ships from the U.S. — same day by 2 PM ET
- Secure checkout · free shipping over $150
Orfo Drive Capsules: Orforglipron and SLU-PP-332 for Research
Technical Overview
Orfo Drive Capsules combine orforglipron and SLU-PP-332 in an oral capsule format (orforglipron 6 mg and SLU-PP-332 0.25 mg per capsule). The formulation is designed for studies of metabolic regulation, cellular energy pathways and systemic balance.
Research applications
- Metabolic regulation: appetite control, glucose pathways and systemic metabolic processes.
- Energy expenditure: mitochondrial activity, PPARδ signaling and endurance-related models.
- Weight regulation models: appetite suppression and energy utilization.
- Cellular signaling: metabolic networks and adaptive energy pathways.
- Systemic balance: regulation across interconnected metabolic systems.
What each ingredient brings
- Orforglipron: a GLP-1 receptor agonist studied for its role in appetite regulation, glucose metabolism and systemic metabolic pathways.
- SLU-PP-332: studied for its influence on PPARδ signaling, mitochondrial efficiency and energy expenditure.
Together, the compounds let researchers investigate how metabolic regulation, cellular energy and systemic pathways interact, with a focus on weight management, glucose sensitivity and energy utilization models.
Format and storage
Supplied as 60 capsules per bottle. Store sealed below 25 °C in a dry place, away from light.
Specifications
Purity: lot COA coming soon
Appearance: Capsules
Format: Capsules
Storage: Below 25 °C, dry
Research Disclaimer
Supplied strictly as a chemical reagent for laboratory investigation. Not for human or veterinary use of any kind.
- Purity
- Lot COA coming soon
- Per capsule
- Orforglipron 6 mg · SLU-PP-332 0.25 mg
- Physical Form
- Capsules
- Storage
- Store sealed below 25 °C in a dry place, away from light
Handling & compliance
Storage & Intended Use
Storage Instructions
Handling and Storage Tips:
- Keep the container tightly sealed, in a cool, dry place below 25 °C and away from direct light.
- Keep any desiccant packet in the container and close the lid promptly after opening.
- Avoid humid areas and large temperature swings; refrigeration is not required.
FDA Disclosure & Intended Use
FDA Disclosure: The statements on this website and the products sold herein have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. Products sold are for Research Use Only and are not for human or animal use.
Intended Purpose: Products sold on this site are intended for laboratory research use only, specifically in vitro studies – experiments conducted outside of living organisms.
Documentation
Certificate of Analysis & Safety Data
Research references
Answers
Frequently Asked Questions
Is there a Certificate of Analysis for Orfo Drive Capsules?
The lot-specific COA for this product is being prepared and will be published here and in our COA library. Contact support if you need the current lot data before ordering.
What does 'Research Use Only' mean?
Products are supplied only for laboratory research. They are not drugs, foods, supplements or cosmetics and are not for human or veterinary use.
How is it shipped and stored?
Shipped with tracking, same day on orders by 2 PM ET. Keep the container sealed, dry and below 25 °C.
More from this category
